
Canopy Growth Corporation (NASDAQ:CGC – Free Report) – Stock analysts at Roth Capital increased their Q3 2026 earnings per share estimates for shares of Canopy Growth in a research report issued to clients and investors on Sunday, November 9th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings of ($0.04) per share for the quarter, up from their prior estimate of ($0.07). The consensus estimate for Canopy Growth’s current full-year earnings is ($2.81) per share.
Canopy Growth (NASDAQ:CGC – Get Free Report) last released its quarterly earnings results on Friday, November 7th. The company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.10. Canopy Growth had a negative net margin of 113.21% and a negative return on equity of 61.97%. The company had revenue of $47.86 million for the quarter, compared to the consensus estimate of $71.82 million.
Check Out Our Latest Research Report on Canopy Growth
Canopy Growth Price Performance
Shares of CGC stock traded up $0.03 during mid-day trading on Wednesday, hitting $1.23. 554,226 shares of the stock traded hands, compared to its average volume of 13,695,815. The company’s 50-day simple moving average is $1.35 and its 200-day simple moving average is $1.35. The firm has a market cap of $293.82 million, a price-to-earnings ratio of -0.63 and a beta of 0.82. Canopy Growth has a twelve month low of $0.77 and a twelve month high of $4.25. The company has a debt-to-equity ratio of 0.31, a quick ratio of 2.12 and a current ratio of 5.50.
Institutional Trading of Canopy Growth
A number of hedge funds have recently modified their holdings of the company. Boothbay Fund Management LLC bought a new stake in shares of Canopy Growth during the second quarter valued at approximately $30,000. Midwest Trust Co acquired a new stake in Canopy Growth during the third quarter worth $31,000. Wealth Enhancement Advisory Services LLC increased its holdings in Canopy Growth by 81.3% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 32,336 shares of the company’s stock valued at $41,000 after buying an additional 14,498 shares during the period. Mackenzie Financial Corp raised its stake in shares of Canopy Growth by 56.5% in the 1st quarter. Mackenzie Financial Corp now owns 50,413 shares of the company’s stock valued at $47,000 after buying an additional 18,202 shares in the last quarter. Finally, Genesee Capital Advisors LLC lifted its holdings in shares of Canopy Growth by 166.1% during the 3rd quarter. Genesee Capital Advisors LLC now owns 40,047 shares of the company’s stock worth $58,000 after acquiring an additional 25,000 shares during the period. Institutional investors own 3.33% of the company’s stock.
Insider Buying and Selling
In other Canopy Growth news, insider Christelle Gedeon sold 16,929 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $1.74, for a total transaction of $29,456.46. Following the completion of the sale, the insider directly owned 368,488 shares in the company, valued at $641,169.12. This represents a 4.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Luc Mongeau acquired 27,469 shares of the stock in a transaction dated Monday, September 22nd. The stock was bought at an average price of $1.82 per share, for a total transaction of $49,993.58. Following the purchase, the chief executive officer owned 812,368 shares of the company’s stock, valued at $1,478,509.76. The trade was a 3.50% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders sold 50,300 shares of company stock worth $84,373. Insiders own 0.16% of the company’s stock.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Recommended Stories
- Five stocks we like better than Canopy Growth
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Occidental Petroleum is a Buy in Q4 2025
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Amazon Is One of the Clearest Buys If the Market Dips Again
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
